Beijing, China

Guozheng Wang

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sironax Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guozheng Wang. Retrieved from https://idiyas.com/inventor/guozheng-wang-88ag1ymw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guozheng Wang: Innovator in Pharmaceutical Chemistry

Introduction

Guozheng Wang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Wang holds a patent for a Difluoro phenyl amide RIP1 inhibitor. The disclosed compounds are designed to inhibit cellular necrosis and include corresponding sulfonamides, prodrugs, and pharmaceutically acceptable salts, hydrates, and stereoisomers. These compounds are utilized in pharmaceutical compositions and methods for treating individuals in need, with the goal of detecting improvements in their health or condition.

Career Highlights

Wang is currently associated with Sironax Ltd., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that address critical health issues.

Collaborations

Wang collaborates with esteemed colleagues, including Zhiyuan Zhang and Yaning Su, who contribute to his research endeavors and enhance the impact of his work.

Conclusion

Guozheng Wang's innovative contributions to pharmaceutical chemistry exemplify the importance of research in developing effective treatments. His work continues to influence the field and improve health outcomes for individuals in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…